Rockabox is a global leader in programmatic technology for rich media marketing and is at the forefront of a revolution that is occurring in the $118 billion online advertising industry.
days to go:
Expired
investment:
£4,274,422
RightIndem is a white-label insurance software platform designed to deliver fast claims to claimants on its portal. The company develops and sells its own proprietary cloud-based digital claim process management software ‘as a service’ to the global insurance market. Insurtech is a vast market and attracts large amounts of investment, with $4.36 billion invested in the first three quarters of 2019. Till date, it has contracted clients such as Axa XL, Archipelago, NN Belgium, NN Netherlands, and Mapfre, with engagements at various levels of implementation and progress in the UK, Italy, Peru, US, and South Africa. They have also earned regard for automating claims processes form some of the world’s largest insurance organizations allowing for the settlement of low to mid-value claims within hours instead of days or months. With the proceeds, the company will connect operating expenses to the point where client revenues from claim volumes match operating costs.
days to go:
Expired
investment:
£200,001
Novai is a UK biotechnology company, developing and commercialising transformational technology in ophthalmology. The company's initial focus is on ophthalmic disorders such as glaucoma and AMD (Age-related Macular Degeneration). Novai argues that current clinical endpoints lack early disease biomarkers to objectively detect and measure cell health and response to treatment in the retina. Novai asserts that its proprietary biological marker, DARC (Detection of Apoptosis in Retinal Cells), combined with its bespoke and patented Artificial Intelligence (AI) aided algorithm, allows, for the first time in vivo, identification of cellular-level disease activity in the retina. Novai stresses that DARC can also predict disease progression, allowing for enrichment of clinical trial cohorts. The company anticipates an exit via licensing of its biomarker business to a Contract Research Organisation (CRO), an Initial Public Offering (IPO) following a successful phase 3 trial of the diagnostic platform, or trade sale to a strategic pharmaceutical company.
days to go:
Expired
investment:
£1,314,967
Lenderwize provides working capital to telecom wholesalers. It asserts that large telecom operators pay on sixty days whilst suppliers are paid on seven days; hence the middleman suffers an average -53 day Cash Flow Gap (CGP). Lenderwize also argues that banks do not understand the telecom industry because a phone call is not a tangible asset such as real estate; hence they provide little help. Lenderwize solves this problem. It has developed a financial technology platform that certifies 'Proof of Service' that includes real phone calls, real invoices and the quality of delivered services. Its typical clients are mid-sized operators having annual revenue of 50-300 million USD. Lenderwize sells to large Tier 1 Operators (Originators) and buys from smaller (Terminating) Operators. It has identified 1350 wholesalers in need of $96 million. Lenderwize intends to exit within four years and sell its business to potential buyers such as large telecom operators, alternative finance funders, and banks seeking innovation.
days to go:
Expired
investment:
£1,310,640
Kaleao has created simple, agile and flexible hardware and software systems which provide 10x more performance per unit of space and consumes 4x less energy. They maintain all promises of the hyperconvergence through the convergence of compute, storage and networking hardware whilst teamed with a full-featured and flexible software platform.
days to go:
Expired
investment:
£2,050,000
Jupiter Diagnostics provide a patent-protected portable reader and test card to provide reliable and cost-effective blood results. Each test card has the ability to measure multiple tests from a prick of blood from the finger and can deliver laboratory-quality results in just ten minutes.
days to go:
Expired
investment:
£2,005,050
JDrew Creations is a dynamic, innovative team of software developers, designers and business professionals whose focus is on delivering flexible, intuitive web systems. This team is the creator of Ambix®, the intranet for membership organisations, helping private communities to network and collaborate securely online.
days to go:
Expired
investment:
£4,522
International Ambulances (IA) aims to save lives and to provide better outcomes for patients, paramedics and hospitals. The company is building a revolutionary ambulance the 'ACESO' that will be the first ever purpose built global ambulance. ACESO will address known challenges of accident & emergency departments and promote the NHS 'See and Treat' strategy. Of the ambulance fleet size of 14,000, International Ambulances (IA) has identified about 1,200 A&E Ambulances of which the opportunity for ACESO is 500 per year.
days to go:
Expired
investment:
£251,600
idio is the leading provider of Content Intelligence: a powerful new way to better understand a customer’s journey and engagement with online content.
www.idioplatform.com
days to go:
Expired
investment:
£1,209,999
Growth Capital Ventures (GCV) is a Financial Conduct Authority (FCA) approved fintech company. GCV's mission is to back the game changers, innovators and value creators. It is operating at three different levels namely, G-Ventures, a specialist software development division; Quva, a private investor network; and G- Labs, an innovation lab. The company aims to provide investors with access to well researched alternative investment opportunities that are selected for their potential to deliver better returns than traditional mainstream investment products. GCV has structured property transactions worth £14.7 million, has 5000+ everyday investors, and seen 500+ jobs created by portfolio companies. GCV will use the investment to grow its business across different verticals.
days to go:
Expired
investment:
£1,295,410
